Cytek Biosciences (CTKB) Short-term Investments (2020 - 2024)

Cytek Biosciences (CTKB) has 4 years of Short-term Investments data on file, last reported at $29000.0 in Q4 2024.

• For the quarter ending Q4 2024, Short-term Investments fell 91.24% year-over-year to $29000.0; the trailing twelve-month figure through Dec 2024 stood at $29000.0 (down 91.24% YoY), and the FY2024 full-year result was $29000.0, down 91.24% from the prior year.
• Short-term Investments for Q4 2024 stood at $29000.0, down from $31000.0 in the prior quarter.
• Across five years, Short-term Investments topped out at $2.9 million in Q1 2023 and bottomed at $29000.0 in Q4 2024.
• The 4-year median for Short-term Investments is $365500.0 (2023), against an average of $940750.0.
• Peak annual rise in Short-term Investments reached 86.29% in 2024, while the deepest fall reached 91.24% in 2024.
• A 4-year view of Short-term Investments shows it stood at $888000.0 in 2020, then soared by 226.46% to $2.9 million in 2022, then slumped by 88.58% to $331000.0 in 2023, then slumped by 91.24% to $29000.0 in 2024.
• The last three Short-term Investments figures came in at $29000.0 (Q4 2024), $31000.0 (Q3 2024), and $30000.0 (Q2 2024), per Business Quant data.

Peer Comparison